ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us and our hands-on approach to production and development that sets us apart. If you are looking for a dynamic, innovative, growing company in the biopharmaceutical industry that is committed to excellence and integrity, then consider ADMA Biologics. We currently have an exciting opportunity available for a Technician I, Donor Center in Goose Creek, SC!
The Technician I, Donor Center, is responsible for ensuring the safety of donors and the compliant collection of plasma following established procedures. Technician I, Donor Center must be capable of interpreting donor screening results in relation to the donor acceptance criteria outlined in company procedures. Responsibilities on the donor phlebotomy floor include the set-up of automated plasmapheresis machines, monitoring of donors throughout the collection process, managing appropriate donor reactions, and completing the disconnection of donors from the automated plasmapheresis machines upon conclusion of the procedure. The Technician I, Donor Center collects appropriate plasma unit samples while ensuring products are frozen and stored in accordance with ADMA procedures. The position sorts and organizes plasma units and samples for product shipment and sample testing. Other duties include arranging inventory stored in the freezer to ensure organization and compliance with standard operating procedures. The Technician I, Donor Center, assists with administrative duties to support and maintain compliance with procedures and regulations. As a representative of the organization, the Technician I, Donor Center consistently delivers professional, courteous, and customer-focused interactions with donors and team members. Strong teamwork, effective communication, and a commitment to continuous learning are essential.
Education Requirements: High school diploma or equivalent required.
In addition to competitive compensation, we offer a comprehensive benefits package including:401K plan with employer match and immediate vestingMedical, Vision, Life and Dental InsurancePet InsuranceCompany paid STD and LTDCompany Paid Holidays3 Weeks’ Paid Time Off (within the first year)Tuition Assistance (after the first year)Easily accessible to Tri-RailFree shuttle to the Boca Tri-Rail stationADMA Biologics uses E-Verify to confirm the employment eligibility of all newly hired employees. To learn more about E-Verify, including your rights and responsibilities, please visit www.dhs.gov/E-Verify.
ADMA Biologics is an Equal Opportunity Employer.

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.